Drug name - Zohydro Er

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9339499 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US10456393 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US10722511 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US10322120 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9326982 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9265760 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9610286 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9333201 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9421200 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US10028946 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9433619 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9132096 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

US9486451 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

US9713611 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

US10092559 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

US9452163 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

Drugs and Companies using HYDROCODONE BITARTRATE ingredient

Treatment: Treatment of pain in patients with hepatic impairment; Treatment of pain

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
10MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
15MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
20MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
30MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
40MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
50MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.